Rossari Historical Balance Sheet

ROSSARI Stock   826.15  18.40  2.18%   
Trend analysis of Rossari Biotech Limited balance sheet accounts such as Total Stockholder Equity of 11 B, Other Liab of 1.9 B, Net Tangible Assets of 6.6 B or Property Plant And Equipment Net of 2.1 B provides information on Rossari Biotech's total assets, liabilities, and equity, which is the actual value of Rossari Biotech to its prevalent stockholders. By breaking down trends over time using Rossari Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Rossari Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rossari Biotech is a good buy for the upcoming year.

Rossari Biotech Inventory

2.96 Billion

  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Rossari Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.

Rossari Biotech Balance Sheet Chart

As of now, Rossari Biotech's Other Liabilities is increasing as compared to previous years. The Rossari Biotech's current Net Tangible Assets is estimated to increase to about 6.6 B, while Total Assets are projected to decrease to under 7.9 B.

Total Assets

Total assets refers to the total amount of Rossari Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rossari Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Rossari Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rossari Biotech Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from Rossari Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
As of now, Rossari Biotech's Other Liabilities is increasing as compared to previous years. The Rossari Biotech's current Net Tangible Assets is estimated to increase to about 6.6 B, while Total Assets are projected to decrease to under 7.9 B.
 2022 2023 2024 (projected)
Short and Long Term Debt Total739.3M1.2B1.2B
Total Assets13.7B15.7B7.9B

Rossari Biotech balance sheet Correlations

0.60.780.990.930.90.921.00.690.190.890.970.840.930.620.670.70.640.770.560.910.890.770.820.991.0
0.60.890.650.750.720.690.580.10.860.80.540.490.720.510.510.520.650.430.490.430.780.920.720.60.63
0.780.890.810.90.880.840.760.420.620.930.740.660.870.460.480.550.660.60.450.580.911.00.790.760.79
0.990.650.810.930.90.910.990.630.250.90.970.820.920.620.690.680.660.770.550.880.890.810.830.990.99
0.930.750.90.930.970.980.930.590.390.990.920.790.990.60.620.680.790.770.560.830.990.90.860.920.93
0.90.720.880.90.970.920.90.660.390.940.850.740.990.510.530.530.770.660.380.870.960.890.940.910.88
0.920.690.840.910.980.920.920.550.310.970.940.790.970.650.670.750.780.820.650.820.960.830.790.910.93
1.00.580.760.990.930.90.920.670.180.890.970.790.930.570.640.650.690.760.520.910.890.760.80.990.99
0.690.10.420.630.590.660.550.67-0.340.490.60.780.640.320.220.430.120.430.210.780.490.390.630.690.63
0.190.860.620.250.390.390.310.18-0.340.470.13-0.030.350.120.180.060.560.060.10.030.480.670.420.190.22
0.890.80.930.90.990.940.970.890.490.470.90.730.970.580.620.660.810.770.560.750.990.930.820.880.91
0.970.540.740.970.920.850.940.970.60.130.90.80.910.640.740.720.680.860.610.860.880.730.730.960.98
0.840.490.660.820.790.740.790.790.78-0.030.730.80.780.790.70.880.270.70.740.810.680.630.730.840.84
0.930.720.870.920.990.990.970.930.640.350.970.910.780.570.60.630.780.740.490.870.980.880.90.930.92
0.620.510.460.620.60.510.650.570.320.120.580.640.790.570.90.90.30.770.870.610.520.450.570.630.66
0.670.510.480.690.620.530.670.640.220.180.620.740.70.60.90.810.440.760.790.630.580.470.580.690.71
0.70.520.550.680.680.530.750.650.430.060.660.720.880.630.90.810.270.740.970.590.580.530.490.670.75
0.640.650.660.660.790.770.780.690.120.560.810.680.270.780.30.440.270.570.240.580.860.70.650.650.64
0.770.430.60.770.770.660.820.760.430.060.770.860.70.740.770.760.740.570.690.660.740.580.550.760.8
0.560.490.450.550.560.380.650.520.210.10.560.610.740.490.870.790.970.240.690.430.470.430.320.530.63
0.910.430.580.880.830.870.820.910.780.030.750.860.810.870.610.630.590.580.660.430.780.590.870.940.88
0.890.780.910.890.990.960.960.890.490.480.990.880.680.980.520.580.580.860.740.470.780.920.850.880.89
0.770.921.00.810.90.890.830.760.390.670.930.730.630.880.450.470.530.70.580.430.590.920.810.760.78
0.820.720.790.830.860.940.790.80.630.420.820.730.730.90.570.580.490.650.550.320.870.850.810.860.79
0.990.60.760.990.920.910.910.990.690.190.880.960.840.930.630.690.670.650.760.530.940.880.760.860.98
1.00.630.790.990.930.880.930.990.630.220.910.980.840.920.660.710.750.640.80.630.880.890.780.790.98
Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

Rossari Biotech balance sheet Accounts

201920202021202220232024 (projected)
Total Assets4.7B5.6B12.6B13.7B15.7B7.9B
Short Long Term Debt Total45.3M669.3M84.3M739.3M1.2B1.2B
Other Current Liab111.1M190.7M157.1M1.1B1.3B1.4B
Total Current Liabilities1.5B1.5B2.9B3.5B4.2B2.2B
Total Stockholder Equity2.9B4.1B8.1B9.2B10.5B11.0B
Other Liab35.6M21.7M23.9M1.6B1.8B1.9B
Net Tangible Assets1.2B2.8B4.0B5.4B6.3B6.6B
Property Plant And Equipment Net1.1B1.7B3.5B3.3B4.3B2.1B
Current Deferred Revenue(329.7M)53.9M903.5M1.2B125.1M118.8M
Net Debt377.2M(152.1M)(290.5M)41.0M936.2M983.0M
Retained Earnings1.6B2.4B3.3B4.4B5.6B5.9B
Accounts Payable970.0M1.3B1.9B1.8B2.2B1.4B
Cash292.1M152.1M374.8M698.3M251.7M254.9M
Non Current Assets Total1.5B2.1B6.5B6.5B7.3B7.7B
Non Currrent Assets Other255.1M55.9M130.5M183.4M104.4M122.5M
Other Assets130.3M255.6M58.9M144.0M165.6M114.4M
Cash And Short Term Investments1.4B883.6M644.3M1.5B667.9M732.6M
Net Receivables941.4M1.5B3.0B(23.4M)4.3B4.5B
Common Stock Shares Outstanding49.3M51.9M55.2M55.4M55.3M53.1M
Short Term Investments1.2B731.5M269.5M819.5M416.2M477.7M
Liabilities And Stockholders Equity4.7B5.6B12.6B13.7B15.7B7.9B
Non Current Liabilities Total361.3M23.9M1.6B1.1B996.9M568.9M
Inventory581.7M953.5M1.9B1.9B2.8B3.0B
Other Current Assets290.8M242.2M500.8M3.8B4.9B5.2B
Other Stockholder Equity1.2B(2.5B)4.6B4.6B4.7B4.9B
Total Liab1.8B1.5B4.5B4.5B5.2B2.8B
Total Current Assets3.3B3.5B6.1B7.2B8.4B4.4B
Short Term Debt313.4M53.9M(714.9M)390.0M745.6M782.9M
Intangible Assets47.7M107.6M1.7B1.5B1.4B1.5B
Common Stock101.5M103.9M110.1M110.3M110.5M91.9M
Property Plant Equipment708.6M1.1B1.7B3.5B4.0B4.2B
Long Term Debt6.7M339.6M0.0349.3M333.2M349.9M
Net Invested Capital3.5B4.1B8.1B9.9B11.5B6.2B
Short Long Term Debt329.7M0.084.3M390.0M725.0M761.3M
Net Working Capital1.8B2.0B3.1B3.7B4.2B2.5B
Capital Stock101.5M103.9M110.1M110.3M110.5M106.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.